BlackRock Investment Management’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-9
| Closed | -$6K | – | 4125 |
|
|
2016
Q1 | $6K | Hold |
9
| – | – | ﹤0.01% | 3759 |
|
|
2015
Q4 | $8K | Buy |
9
+1
| +13% | +$889 | ﹤0.01% | 3749 |
|
|
2015
Q3 | $8K | Hold |
8
| – | – | ﹤0.01% | 3782 |
|
|
2015
Q2 | $16K | Buy |
8
+5
| +167% | +$10K | ﹤0.01% | 3507 |
|
|
2015
Q1 | $3K | Hold |
3
| – | – | ﹤0.01% | 3933 |
|
|
2014
Q4 | $3K | Hold |
3
| – | – | ﹤0.01% | 4003 |
|
|
2014
Q3 | $3K | Hold |
3
| – | – | ﹤0.01% | 3968 |
|
|
2014
Q2 | $5K | Sell |
3
-50
| -94% | -$83.3K | ﹤0.01% | 3867 |
|
|
2014
Q1 | $114K | Hold |
53
| – | – | ﹤0.01% | 3267 |
|
|
2013
Q4 | $122K | Sell |
53
-1
| -2% | -$2.3K | ﹤0.01% | 3249 |
|
|
2013
Q3 | $154K | Buy |
54
+3
| +6% | +$8.56K | ﹤0.01% | 3202 |
|
|
2013
Q2 | $467K | Buy |
+51
| New | +$467K | ﹤0.01% | 2880 |
|